These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35955107)

  • 21. "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.
    Bass SB; Kelly PJA; Pandit-Kerr S; Pilla J; Morris K; Larsen E; Wisdom JP; Torralva PR
    Front Public Health; 2022; 10():882421. PubMed ID: 35937263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Social Isolation during the COVID-19 Pandemic on Mental Health, Substance Use, and Homelessness: Qualitative Interviews with Behavioral Health Providers.
    Jeffers A; Meehan AA; Barker J; Asher A; Montgomery MP; Bautista G; Ray CM; Laws RL; Fields VL; Radhakrishnan L; Cha S; Christensen A; Dupervil B; Verlenden JV; Cassell CH; Boyer A; DiPietro B; Cary M; Yang M; Mosites E; Marcus R
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic.
    Watson DP; Staton MD; Grella CE; Scott CK; Dennis ML
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):22. PubMed ID: 35303913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
    Krawczyk N; Bandara S; Merritt S; Shah H; Duncan A; McEntee B; Schiff M; Ahmad NJ; Whaley S; Latimore A; Saloner B
    Addict Sci Clin Pract; 2022 Jun; 17(1):30. PubMed ID: 35655293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic.
    Bunting AM; Frank D; Arshonsky J; Bragg MA; Friedman SR; Krawczyk N
    Drug Alcohol Depend; 2021 May; 222():108672. PubMed ID: 33757708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data.
    Aronowitz SV; Carroll JJ; Hansen H; Jauffret-Roustide M; Parker CM; Suhail-Sindhu S; Albizu-Garcia C; Alegria M; Arrendondo J; Baldacchino A; Bluthenthal R; Bourgois P; Burraway J; Chen JS; Ekhtiari H; Elkhoy H; Farhoudian A; Friedman J; Jordan A; Kato L; Knight K; Martinez C; McNeil R; Murray H; Namirembe S; Radfar R; Roe L; Sarang A; Scherz C; Tay Wee Teck J; Textor L; Thi Hai Oanh K
    Glob Public Health; 2022 Dec; 17(12):3654-3669. PubMed ID: 36692903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions.
    Salamanca-Buentello F; Cheng DK; Sabioni P; Majid U; Upshur R; Sud A
    Int J Drug Policy; 2022 Mar; 101():103556. PubMed ID: 34902805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program.
    Walters JE; Jones AE; Brown AR; Wallis D
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "A Lot of Things Stopped with COVID": Screening Pregnant Patients for Opioid Use and Related Conditions During the COVID-19 Pandemic.
    Foti TR; Vereen S; Vamos C; Sappenfield W; Kirby RS
    Womens Health Issues; 2023; 33(3):242-249. PubMed ID: 36496340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of individuals in treatment for substance use disorder during COVID-19: insight on mental health, sobriety, access to treatment, and telehealth.
    Bayers T; Strohmaier T; Shreffler J; Huecker M
    J Addict Dis; 2022; 40(1):111-113. PubMed ID: 34296654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using a structural vulnerability framework to understand the impact of COVID-19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City.
    Zhen-Duan J; Gade N; Falgas-Bagué I; Sue KL; DeJonckheere M; Alegría M
    Health Serv Res; 2022 Oct; 57(5):1104-1111. PubMed ID: 35340033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How did the first COVID-19 lockdown affect persons with concurrent mental health and substance use disorders in Norway? A qualitative study.
    Leonhardt M; Brodahl M; Cogan N; Lien L
    BMC Psychiatry; 2022 Mar; 22(1):179. PubMed ID: 35287637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
    Henderson R; McInnes A; Mackey L; Bruised Head M; Crowshoe L; Hann J; Hayward J; Holroyd BR; Lang E; Larson B; Leonard AJ; Persaud S; Raghavji K; Sarin C; Virani H; Wadsworth IW; Whitman S; McLane P
    BMC Public Health; 2021 Jul; 21(1):1471. PubMed ID: 34320954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.